Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2GoalSM concept

O. Cohen*, Z. Agabria, L. Lysyy, Y. Ianovitsky, X. Nguyen, M. Fung, S. Lee, J. Wainstein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background: The goal is to assess the usability and satisfaction of implementing the Getting2GoalSM protocol by physicians transitioning patients with type 2 diabetes (T2DM) from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII). Methods: T2DM patients from three diabetes clinics were switched from MDI to CSII. Physicians used the Getting2Goal type 2 pumping protocol to prescribe and manage insulin pump therapy for T2DM. Surveys were conducted in which the physicians rated their feedback related to acceptability of the Getting2Goal on a 5-point Likert scale. Results: 17 patients with T2DM were switched from MDI to CSII treatment. Mean (±standard deviation) age was 61.2 ± 7.7 (46–77) years, weight was 91.4 ± 21 (66–147) kg, BMI was 31.9 ± 7.6, A1C was 9.2 ± 1.4 % (7.2–12.3) and TDD on MDI was 109.1 ± 53.1 units. Surveys completed by physicians indicated Getting2Goal type 2 pumping protocol to be more efficient, time saving, and structured compared to their current processes. In addition, the primarily prescribed TDD on pump was 98.1 ± 50.0 units and the TDD at first download was 81.4 ± 36.4 units, representing a 25.4 % reduction in TDD At first download. The percentage of all blood glucose readings below 70 mg/dL was also very low. Conclusions: The data indicate Getting2Goal materials as a standard approach that is simple and efficient to initiate pump therapy for T2DM. At the same time, it is safe and a useful tool for physicians that are starting to prescribe pump therapy for T2DM.

Original languageEnglish
Pages (from-to)627-633
Number of pages7
JournalJournal of Endocrinological Investigation
Volume39
Issue number6
DOIs
StatePublished - 1 Jun 2016

Funding

FundersFunder number
Sanofi
Medtronic

    Keywords

    • CareLink
    • Continuous subcutaneous insulin infusion
    • Total daily dose
    • Type 2 diabetes

    Fingerprint

    Dive into the research topics of 'Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2GoalSM concept'. Together they form a unique fingerprint.

    Cite this